(Q35693684)

English

Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chr

scientific article published on March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Successful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chr (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

0 references

1 reference

based on heuristic

inferred from title

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

author name string

Robert E Click

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

131-143

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Adverse effects of biologics: a network meta-analysis and Cochrane overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Assessment of Dietzia subsp. C79793-74 for treatment of cattle with evidence of paratuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Comparison of ante-mortem assays to assess progression/regression of paratuberculosis in individual dairy animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Detection of Mycobacterium avium ss. Paratuberculosis in Blau Syndrome Tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics and prebiotics in pediatrics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics for treating acute infectious diarrhoea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Innate antimicrobial immunity in inflammatory bowel diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Long‐Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta‐Analysis of Placebo‐Controlled Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Helminthic therapy: using worms to treat immune-mediated disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics promote gut health through stimulation of epithelial innate immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

The path to Crohn's disease: is mucosal pathology a secondary event?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Adalimumab safety in global clinical trials of patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

A patented strain of Bacillus coagulans increased immune response to viral challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics as prevention and treatment for diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics in functional gastrointestinal disorders: what are the facts?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

What is the evidence for the use of probiotics in functional disorders?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Pathogenic agents in inflammatory bowel diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

The evidence for Mycobacterium paratuberculosis in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics in the management of colonic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

The role of probiotics in management of irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

In utero infection of cattle with Mycobacterium avium subsp. paratuberculosis: a critical review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Review article: the evidence base for interventions used to maintain remission in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

The mechanism of action of probiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Effects of experimental immunosuppression in cattle with persistently high antibody levels to Salmonella Dublin lipopolysaccharide O-antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Combined Streptomycin-Isoniazid-Rifampin Therapy in the Treatment of Johne's Disease in a Goat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Helminths as governors of immune-mediated inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Safety of biologic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Adherent-invasive Escherichia coli and Crohnʼs disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

A new look at Crohn's disease: breakdown of the mucosal antibacterial defense

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotics in the treatment of inflammatory bowel disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Review article: practical management of inflammatory bowel disease patients taking immunomodulators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotic therapy of intestinal inflammation and infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Long-term risks associated with biologic response modifiers used in rheumatic diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Natalizumab for active Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Corticosteroids in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Prevention and treatment of osteoporosis in patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

The pathology and pathogenesis of paratuberculosis in ruminants and other species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Identification of Mycobacterium avium complex in sarcoidosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Treatment of clinical paratuberculosis in cattle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Preclinical and clinical manifestations of paratuberculosis (including pathology).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Immunology: resistance to paratuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Crohn's disease and the mycobacterioses: a review and comparison of two disease entities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Bacterial evolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Treatment of Mycobacterium Paratuberculosis Infection in Ruminants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

27 July 2018

Crohn's disease as an immunodeficiency

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Safety of infliximab and other biologic agents in the inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Probiotics: an emerging therapy.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Gut Pathogens: enteric health at the interface of changing microbiology

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Genetic variation of susceptibility to Mycobacterium avium subsp. paratuberculosis infection in dairy cattle

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Genetic variation and heritability of the antibody response to Mycobacterium avium subspecies paratuberculosis in Danish Holstein cows

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Association between CARD15/NOD2 gene polymorphisms and paratuberculosis infection in cattle

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

The incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Inside the microbial and immune labyrinth: Gut microbes: friends or fiends?

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Alterations in intestinal microbial flora and human disease

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls.

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Durable alteration of the colonic microbiota by the administration of donor fecal flora

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

High-dose probiotics for the treatment of active pouchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

Probiotics for maintenance of remission in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

Ruminant paratuberculosis (Johne's disease): the current status and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

Candidate gene polymorphisms (BoIFNG, TLR4, SLC11A1) as risk factors for paratuberculosis infection in cattle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

25 September 2018

NOD2/CARD15 mutations in Croatian patients with Crohn??s disease: prevalence and genotype???phenotype relationship

1 reference

https://api.crossref.org/works/10.4161%2FVIRU.2.2.15647

21 January 2018

Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3265756

15 November 2018

Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic variation of Mycobacterium avium ssp. paratuberculosis infection in US Holsteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutrition in Crohn disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to infliximab is related to disease duration in paediatric Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of a Crohn's disease patient infected with bacteremic Mycobacterium paratuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-mycobacterials and Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short communication: progression of Johne's disease curtailed by a probiotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/21460639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/VIRU.2.2.15647

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35693684&oldid=1796605081"